home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,225 rows where filing_year = 2024 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • second_quarter 315
  • first_quarter 314
  • third_quarter 302
  • fourth_quarter 294

issue_code 1

  • MED · 1,225 ✖

filing_year 1

  • 2024 · 1,225 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3138214 MARSHALL BRACHMAN eb9272e6-8646-4861-ac60-a90bcde2db9f 1T MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2024 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 24000   0 1 2024-03-05T14:56:16-05:00
3138459 REPUBLIC CONSULTING, LLC e776dab9-33ed-4096-9150-37da7e408176 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2024 first_quarter MED Monitor Health Data Policy. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-03-29T12:19:47-04:00
3138489 FRANCIS EDWARD & CRONIN, INC. b7016781-bfad-4ed8-8f20-dd49658edb33 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2024 first_quarter MED Legislation related to Alzheimer's disease research Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-03-31T12:22:42-04:00
3138490 FRANCIS EDWARD & CRONIN, INC. 5cffa855-209f-4538-9972-dc9154aee29e Q1 FRANCIS EDWARD & CRONIN, INC. 311314 USAGAINSTALZHEIMER'S 2024 first_quarter MED Legislation related to the treatment, detection, and prevention of Alzheimer's disease Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-03-31T12:24:32-04:00
3138499 HASHEMI STRATEGIC ADVISORS c65b5ff7-b3cb-495e-ba1c-80905c1c7ee4 1T HASHEMI STRATEGIC ADVISORS 401108007 ULTRAGENYX 2024 first_quarter MED Rare and Ultrarare genetic diseases HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2024-04-01T00:09:17-04:00
3138586 HELIX, INC. ca351427-ce8d-4a70-805e-e13ac3dc1ded Q1 HELIX, INC. 401106164 HELIX, INC. 2024 first_quarter MED Oversight of Lab Developed Tests, express legislative authority. Viral Surveillance in clinical settings. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   83000 0 0 2024-04-01T11:07:53-04:00
3138817 RAY C CULVER III 186e6ef5-3176-41ab-928f-e390915b9394 Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2024 first_quarter MED Funding for USDA ARS human nutrition research funding in the Consolidated Appropriations Act, 2024, and in the FY2025 appropriation bills. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-01T20:36:31-04:00
3138824 OCAL LOBBYING GROUP 35e5d816-4f5e-4b6d-a30e-cb9a0af259e5 Q1 OCAL LOBBYING GROUP 401106825 SAMERA S.A. 2024 first_quarter MED Obtain funding for Tuberculosis monitoring. Natl Institutes of Health (NIH)     0 0 2024-04-02T07:25:38-04:00
3138892 AUBURN HEALTH STRATEGIES, LLC d7924075-9e85-46d3-8e76-f5bb55176357 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2024 first_quarter MED proficiency testing for clinical laboratories       0 0 2024-04-02T10:47:58-04:00
3138970 EMERGENT STRATEGIES 7655a53f-5a73-429a-9071-b068e696c7ff Q1 EMERGENT STRATEGIES 401104778 ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2024 first_quarter MED Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2024-04-02T13:46:56-04:00
3138979 AMERICAN COLLEGE OF CLINICAL PHARMACY e7423c4b-9da7-41ca-8098-5280709b1e59 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2024 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2024-04-02T13:50:47-04:00
3139014 O'NEILL AND ASSOCIATES af595c6f-5db0-4521-a990-d5dd74c8aa98 Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2024 first_quarter MED Healthcare, Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-04-02T14:55:59-04:00
3139029 MAGILL ASSOCIATES, LLC 3968df92-ea40-419d-8bc9-69e521cbdcd9 Q1 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2024 first_quarter MED FY 2024 and FY 2025 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES 20000   0 0 2024-04-02T15:43:31-04:00
3139043 THE DLM GROUP cc2f96e2-744c-4e42-bd38-b4213fbbf0dc Q1 THE DLM GROUP 313794 GENESIS HEALTH CARE, INC. 2024 first_quarter MED no activity HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-04-02T15:59:10-04:00
3139130 THE HARRIS FIRM 59b20070-c91f-4b2d-8ad7-328ef970fa80 Q1 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2024 first_quarter MED Issues pertaining to cannabis CSA scheduling. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-02T16:49:20-04:00
3139411 LOBBYIT.COM 661f5a27-e854-48ac-baca-763a89f8ddf1 Q1 LOBBYIT.COM 400487397 BRAIN ANEURYSM FOUNDATION 2024 first_quarter MED Advocate for the passage of Ellie's Law (H.R. 902, S. 895) Creation of a dedicated Brain Aneurysm Caucus Appropriation Requests HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-03T14:16:19-04:00
3139625 SQUIRE PATTON BOGGS 230da5aa-3dfa-4ecf-9048-a39ff417586a Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2024 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2024-04-04T09:43:53-04:00
3139870 CAPSTONE NATIONAL PARTNERS 00e54f12-f3a5-4291-a2dc-87eea70b1c28 Q1 CAPSTONE NATIONAL PARTNERS 8214 ATTERX BIOTHERAPEUTICS 2024 first_quarter MED research funding HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-04-04T15:17:42-04:00
3139887 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. b3798696-7417-415a-b9d9-5e076d73ac36 Q1 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 52925 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 2024 first_quarter MED MED HR 3226/S 1573: Prematurity Research Expansion and Education for Mothers who Deliver Infants Early (PREEMIE) Reauthorization Act of 2023 All Provisions This bill would reauthorize critical federal research, education and care to reduce preterm birth and infant mortality. MED HR 4534/S 2245 - Women and Lung Cancer Research and Preventative Services Act of 2023 All provisions This bill requires a review of women and lung cancer. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-04-04T15:36:35-04:00
3139917 FEDERAL SOLUTIONS, LLC 7c651ae4-0a98-48a0-829a-6c1943dd6113 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2024 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-04T17:26:14-04:00
3140296 BEN BARNES GROUP LP 08dcda5f-80a7-406b-85fb-a1cbbb6ce579 Q1 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2024 first_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2024-04-07T13:13:35-04:00
3140300 BEN BARNES GROUP LP 36239305-e95e-4b47-b22a-446f60c6f555 Q1 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2024 first_quarter MED Medical/Disease Research SENATE 11500   0 0 2024-04-07T13:25:16-04:00
3140305 BEN BARNES GROUP LP c91aab78-e16f-41dc-ac1a-ce5a7b564ac0 Q1 BEN BARNES GROUP LP 5415 CLENE NANOMEDICINE, INC. 2024 first_quarter MED ALS HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2024-04-07T13:44:56-04:00
3140465 THE CONSILIO GROUP 70eec3d9-1da0-4ec5-bee3-0f0e4d5c2c7c Q1 THE CONSILIO GROUP 400374717 DETECTACHEM 2024 first_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2024-04-08T10:44:31-04:00
3140520 WATKINS & EAGER PLLC 30301792-954e-40a4-a8dc-9d0797a7170d Q1 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2024 first_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-04-08T11:35:51-04:00
3140558 FONTENOT HEALTH POLICY LLC 56935300-8300-47fe-946c-4609da53300d Q1 FONTENOT HEALTH POLICY LLC 401107703 ORGANIZE DBA ORGANIZE ACTION NETWORK 2024 first_quarter MED Organ Procurement reforms; Revisions to the Outcme Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486); Organ Procurement Organizations Conditions of Coverage; S. 1688/H.R. 2544 Securing the U.S. Organ Procurement and Transplantation Network Act   10000   0 0 2024-04-08T12:17:12-04:00
3140638 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) b5b495ee-5fe2-4caf-9003-682171b170b9 Q1 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2024 first_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-08T14:25:18-04:00
3140652 MCDERMOTT+ LLC 8ef2e13b-aeb3-43b4-92ab-98d3b199a81f Q1 MCDERMOTT+ LLC 401103287 VERILY LIFE SCIENCES LLC 2024 first_quarter MED Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-04-08T14:33:16-04:00
3140763 2359 STRATEGIES 9901c974-9530-4210-a8ee-c8a75fc674da Q1 2359 STRATEGIES 401106114 TRAVERE THERAPEUTICS 2024 first_quarter MED Rare kidney disease HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2024-04-08T20:03:07-04:00
3141118 MASON STREET CONSULTING, LLC 6654a24c-e811-43a5-88bb-2122dc01dc80 Q1 MASON STREET CONSULTING, LLC 401105150 PERIMETER MEDICAL IMAGING 2024 first_quarter MED Advanced Research Projects Agency for Health (ARPA-H). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-04-09T14:34:30-04:00
3141241 TRUSYNERGY 0c3fda88-cb4d-41d4-be54-dcc8df9ff64f Q1 TRUSYNERGY 401107715 BURRELL INTERNATIONAL GROUP (ON BEHALF OF ARSENAL MEDICAL, INC.) 2024 first_quarter MED Funding for medical devices for hemorrhages; provisions in FY24 NDAA and FY24 Defense Appropriations HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2024-04-10T06:29:24-04:00
3141301 SQUIRE PATTON BOGGS 684a0ce4-ba15-4d20-b63f-d88fb9d1d7b2 Q1 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2024 first_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-04-10T11:09:24-04:00
3141368 TRUSYNERGY 53ada252-806b-499d-8919-a73475338f8a Q1 TRUSYNERGY 401107715 BURRELL INTERNATIONSL GROUP (ON BEHALF OF OTOGENETICS) 2024 first_quarter MED Funding for genetic testing and carrier screening, women's health, diagnostic equity, FY 24 appropriations, FY 25 appropriations, FY 25 NDAA Defense, Dept of (DOD)     0 0 2024-04-10T12:32:35-04:00
3141389 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) a1b89058-6baf-4373-9a92-3148a5742afa Q1 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2024 first_quarter MED * On January 24, ADLM and the American Society for Microbiology wrote to the Centers for Medicare and Medicaid Services requesting that the agency reconsider its decision to recognize a Doctorate in Clincal Laboratory Science as an accepted PhD for high complexity laboratory directors under the CLIA regulations. *On March 18, ADLM met with, and submitted comments to, Office of Management and Budget staff in opposition to the release of the Food and Drug Administration final rule on laboratory developed tests. * On March 21, ADLM submitted testimony to the House Energy and Commerce Committee Subcommittee on Health raising concerns about FDA oversight of LDTs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB)   50000 0 0 2024-04-10T13:46:35-04:00
3141918 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 5a89e603-12ca-4295-a077-cf0b3e00b1be Q1 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2024 first_quarter MED NONE     10000 0 0 2024-04-11T12:16:44-04:00
3142534 PARALYZED VETERANS OF AMERICA 3ae40d67-c4d1-451e-acd2-b4147f8e5677 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2024 first_quarter MED Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   74465 0 0 2024-04-12T11:49:24-04:00
3142721 TIBER CREEK GROUP dc84415d-a6e7-4a55-9dce-e0c9ffb05935 Q1 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2024 first_quarter MED Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-12T13:46:53-04:00
3142916 OLD NORTH STRATEGIES, LLC c62267ab-b70a-4d04-963f-d1540852cda6 Q1 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2024 first_quarter MED supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 108000   0 0 2024-04-12T16:14:35-04:00
3143267 FORBES-TATE e353961c-d642-43c7-b862-dae7cda04fca Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2024 first_quarter MED Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-12T19:30:12-04:00
3143295 FORBES-TATE e4b7414e-4bc5-466e-bd27-ecfb3b7b77d4 Q1 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2024 first_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-12T19:50:19-04:00
3143316 CORNERSTONE GOVERNMENT AFFAIRS, INC. 081f1c72-ed1a-463e-af6b-73c90f70c556 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 HAZELDEN BETTY FORD FOUNDATION 2024 first_quarter MED Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-12T20:20:59-04:00
3143395 FORBES-TATE 64a0bbc3-1f8a-4922-9a46-fcecfd7257dc Q1 FORBES-TATE 400976792 CSL BEHRING 2024 first_quarter MED Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. - 6465 Preserving Life-saving Access to Specialty Medicines in America Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-04-12T21:10:20-04:00
3143400 CORNERSTONE GOVERNMENT AFFAIRS, INC. 05d13112-16d4-4000-9e7e-2fef5bf7698d Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OU MEDICINE, INC. 2024 first_quarter MED Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-12T21:13:40-04:00
3143449 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 1b9ee0db-1be8-4495-a398-984eb3f8c550 Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2024 first_quarter MED NIH funding, PACT Act, Accelerating Kids Access Act, NIH reform Senate HELP Minority RFI, genomic testing, LDT testing FDA rule, NICHD workforce reform including K12 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   35600 0 0 2024-04-13T09:16:53-04:00
3143605 CHAMBER HILL STRATEGIES 1e416e05-f53c-48b1-a41b-af8a0276d87d Q1 CHAMBER HILL STRATEGIES 400645947 MAYO COLLABORATIVE SERVICES, INC. 2024 first_quarter MED Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-04-13T17:17:20-04:00
3143936 FORBES-TATE 100d0167-fb20-428f-9737-1f5d1acc3da6 Q1 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2024 first_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-14T12:26:33-04:00
3144059 CORNERSTONE GOVERNMENT AFFAIRS, INC. 9458addc-28e1-4c69-ad88-38f5d6d17fbf Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2024 first_quarter MED Congressional outreach related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-14T18:05:38-04:00
3144072 THE PETRIZZO GROUP, INC. f046ec2a-3324-4ad0-a507-d6b2dce9d6e3 Q1 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2024 first_quarter MED Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 75000   0 0 2024-04-14T18:13:00-04:00
3144180 FORBES-TATE cdfab3a0-b4ff-4914-be3b-787af7e47f61 Q1 FORBES-TATE 400976792 AMGEN USA, INC. 2024 first_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2024-04-14T21:03:02-04:00
3144436 WILLIAM SCHMIDT 7513a8a3-9cb0-486f-8490-e38f5caa81f7 Q1 WILLIAM SCHMIDT 401107557 PULMONARY FIBROSIS FOUNDATION 2024 first_quarter MED Funding for the National Institutes of Health Funding for the Congressionally Directed Medical Research Program at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-04-15T09:02:58-04:00
3144466 IPOLICY SOLUTIONS 8d195101-09b9-4eb1-8a87-1fc2e1bb71e3 Q1 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2024 first_quarter MED No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 70500   0 0 2024-04-15T09:44:32-04:00
3144477 IPOLICY SOLUTIONS 3a8b334a-d4f9-43a2-850b-66b9332ccda3 Q1 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2024 first_quarter MED H.R.2369 - VALID Act of 2023 FDA Proposed rule on LDTs HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 40000   0 0 2024-04-15T09:50:14-04:00
3144624 TENAGRITY SOLUTIONS, LLC 0d888fc1-4e0c-4dd6-bf91-a9bd7c6467c4 Q1 TENAGRITY SOLUTIONS, LLC 401107856 KARDIOGENICS, INC. 2024 first_quarter MED Preparation to introduce client to congressional offices re: how their health work can help with defense HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-04-15T11:06:07-04:00
3144633 TENAGRITY SOLUTIONS, LLC 510c0c32-b562-4d94-b8b7-526e020127dd Q1 TENAGRITY SOLUTIONS, LLC 401107856 1DAY SOONER ACTION PROJECT 2024 first_quarter MED S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY24 & FY25 appropriations to ensure adequate resources for HHS for pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA Assistance with a letter of support from the US House (and pursuing one from the Senate) to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines . To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 20000   0 0 2024-04-15T11:28:00-04:00
3144868 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 0cd49e77-9739-4df0-b6f7-ed3357274dcc Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2024 first_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-04-15T12:52:02-04:00
3145045 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 915d4b15-2fad-486e-af7e-e4a47b83816e Q1 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2024 first_quarter MED Warning label transparency and evaluation process Medication and vaccine access Clinical trial diversity and equity Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   15000 0 0 2024-04-15T13:55:30-04:00
3145055 THE CONSILIO GROUP 7389894e-6d6d-4efe-b194-ebdf3d994b5f 1A THE CONSILIO GROUP 400374717 DETECTACHEM 2024 first_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2024-04-15T13:58:48-04:00
3145080 IMPACT MANAGEMENT GROUP ae7c0b42-46cd-4d49-beae-a8a23e91bf1b Q1 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2024 first_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-04-15T14:15:29-04:00
3145118 IMPACT MANAGEMENT GROUP 2abcf7a0-cc26-431c-a5f0-2680766740b5 Q1 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2024 first_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2024-04-15T14:28:11-04:00
3145306 CORNERSTONE GOVERNMENT AFFAIRS, INC. ade4c6b9-f42f-4f35-93f7-ad9bb491df34 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2024 first_quarter MED Discussions regarding patient access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2024-04-15T15:40:16-04:00
3145407 THE LIVINGSTON GROUP, LLC d5f11fee-e27b-4f90-a5ac-6806366daab4 Q1 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2024 first_quarter MED FY2024 and FY2025 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES 30000   0 0 2024-04-15T16:16:14-04:00
3145600 CORNERSTONE GOVERNMENT AFFAIRS, INC. 1689c9b8-3937-43e0-8494-e65cd6267f9e Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNIVERSITY OF TEXAS SYSTEM 2024 first_quarter MED Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2024-04-15T17:12:59-04:00
3145769 COVINGTON & BURLING LLP 50d97a55-2068-4188-bcb9-201541b2d12f Q1 COVINGTON & BURLING LLP 11195 RWE ALLIANCE INC. 2024 first_quarter MED Real-world health data and analytics policy.   60000   0 0 2024-04-15T19:05:32-04:00
3145852 ALPINE ADVISORS 597e4313-8f59-43d3-ba0b-513b3e9c050b Q1 ALPINE ADVISORS 401106595 COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION 2024 first_quarter MED Issues pertaining to government-wide federal regulation of cannabis HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-16T06:52:21-04:00
3145916 EFB ADVOCACY, LLC b3063f03-092a-4354-9bd8-4de743eaa8f8 Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2024 first_quarter MED Funding Issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-04-16T09:33:24-04:00
3146553 THE JACKSON LABORATORY 94a5d184-aefe-4704-b1e5-ea2d44ddad57 Q1 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2024 first_quarter MED Issues related to biomedical research. Animal model use in biomedical research. HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   30000 0 0 2024-04-16T13:50:07-04:00
3146663 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 8ce7fbfe-4dfc-435d-b80d-3f9a3b5a6f9a Q1 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 26557 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 2024 first_quarter MED Support funding for biomedical research HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2024-04-16T14:20:17-04:00
3147285 TIDES GROUP, LLC 58751405-0e86-4fd6-8b39-188998573537 1T TIDES GROUP, LLC 401105835 AGENUS INC. 2024 first_quarter MED Issues related to colorectal cancer immunotherapy. HOUSE OF REPRESENTATIVES 30000   0 1 2024-04-16T16:30:48-04:00
3147326 ARENTFOX SCHIFF LLP a53c33cc-3000-4698-b52b-b5051662d584 Q1 ARENTFOX SCHIFF LLP 4208 INFECTIOUS DISEASES SOCIETY OF AMERICA 2024 first_quarter MED H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-04-16T16:39:13-04:00
3148119 JEFFREY J. KIMBELL & ASSOCIATES, INC. 7273421b-b1bc-43f0-a6db-264406663b6a Q1 JEFFREY J. KIMBELL & ASSOCIATES, INC. 46038 ANIVIVE LIFESCIENCES 2024 first_quarter MED issues related to Valley Fever and fungal vaccines HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-04-17T11:14:25-04:00
3148533 AMERICAN PHYSICAL THERAPY ASSOCIATION a86b845b-d749-4cb2-8b17-8cc100831e30 Q1 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2024 first_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   277054 0 0 2024-04-17T12:38:56-04:00
3149143 UNIVERSITY OF KENTUCKY 54120e20-0ac6-4ae6-9c5a-8ebe392aa006 Q1 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2024 first_quarter MED Barriers to research with Schedule 1 drugs NCI funding for FY24 HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   184323 0 0 2024-04-17T14:52:07-04:00
3149339 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES a5a5f5e5-cab8-44c4-8dd6-3c2d31e81bac Q1 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2024 first_quarter MED H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R. 3795 The Diagnostics Testing Preparedness Plan Act, H.R. 3631 The State Stockpile Act, H. R. 5846 Protecting America from Seasonal and Pandemic, Influenza Act of 2023 (the Influenza Act) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA) and 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 HOUSE OF REPRESENTATIVES,SENATE   180000 0 0 2024-04-17T15:36:20-04:00
3149435 BROWNSTEIN HYATT FARBER SCHRECK, LLP 91720acf-c9ad-43bc-9c11-bb4f00f20c2a Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 MARIDOSE LLC 2024 first_quarter MED Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-17T16:01:26-04:00
3149472 UNIVERSITY OF GEORGIA a5478094-7184-4765-8c9c-52edb6825d53 Q1 UNIVERSITY OF GEORGIA 40032283 UNIVERSITY OF GEORGIA 2024 first_quarter MED Federal research funding HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2024-04-17T16:14:39-04:00
3149553 DA VINCI GROUP 49c0d06f-685c-489e-8425-3a851ad321d1 Q1 DA VINCI GROUP 11548 KAI MEDICAL LABORATORY 2024 first_quarter MED Funding for Clinical Research & Diagnostics Programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-17T16:34:44-04:00
3149838 CORNERSTONE GOVERNMENT AFFAIRS, INC. df9d2982-03b5-4910-b374-b1616d8f5acc Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2024 first_quarter MED Health-related issues including reimbursement, research, public-health & clinical care. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2024-04-17T18:03:43-04:00
3150058 IMPACT HEALTH POLICY PARTNERS 40b67b0a-d608-4427-9021-fe23f7ab6873 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2024 first_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-18T08:17:13-04:00
3150062 IMPACT HEALTH POLICY PARTNERS c959412a-a15b-4d54-ad83-aafecd52f666 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2024 first_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-18T08:20:26-04:00
3150068 IMPACT HEALTH POLICY PARTNERS 1753ca9c-3564-4823-846b-46cbe3c62538 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2024 first_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2024-04-18T08:26:27-04:00
3150192 STANFORD UNIVERSITY 5560fed5-1064-4771-99c9-9d82acd21255 Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2024 first_quarter MED HR 2389 Resident Physician Shortage Reduction Act of 2023 AI healthcare-related research Antiviral drug research / Antiviral Drug Discovery Centers HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   90000 0 0 2024-04-18T09:30:29-04:00
3150408 MANATT, PHELPS, AND PHILLIPS 0337355d-0a2e-463b-bb1e-6871cca0bca6 Q1 MANATT, PHELPS, AND PHILLIPS 23645 LOMA LINDA UNIVERSITY MEDICAL CENTER 2024 first_quarter MED Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF   140481   0 0 2024-04-18T10:22:35-04:00
3150423 MANATT, PHELPS, AND PHILLIPS feb185f0-e7c0-4f69-8a1b-6b63ffdd4feb Q1 MANATT, PHELPS, AND PHILLIPS 23645 MEDISYS HEALTH NETWORK 2024 first_quarter MED Provider Relief and COVID funding and other healthcare issues; Community Project Funding   44000   0 0 2024-04-18T10:25:24-04:00
3150597 WILLIAMS AND JENSEN, PLLC 416ee0e5-de06-4225-a669-7eb6a252e4ef Q1 WILLIAMS AND JENSEN, PLLC 41454 THE JED FOUNDATION 2024 first_quarter MED General education about mental health and suicide prevention programs. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-18T10:54:35-04:00
3150693 WILLIAMS AND JENSEN, PLLC b974dfc8-285c-40f0-a189-8defe6f906de Q1 WILLIAMS AND JENSEN, PLLC 41454 CALIFORNIA LIFE SCIENCES 2024 first_quarter MED General information about Medicare coverage and payment for drugs and devices including drug pricing legislation, "Inflation Reduction Act" implementation and changes including the EPIC Act and Orphan Cures Act, Pharmacy benefit manager reform proposals, and Medicare coverage for breakthrough devices. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-18T11:09:33-04:00
3150737 AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION c2302ec3-5f68-4b81-9d72-3eafe7abe468 Q1 AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION 1331 AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION 2024 first_quarter MED Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624. Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R.4635/S.2587). Support H.R.3503,NIH Clinical Trial Diversity Act. HOUSE OF REPRESENTATIVES,SENATE   700000 0 0 2024-04-18T11:24:09-04:00
3150787 BUCHANAN INGERSOLL & ROONEY PC 72522a53-10c5-49d5-9263-000060cd32f4 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2024 first_quarter MED Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-04-18T11:37:51-04:00
3150821 SPINA BIFIDA ASSOCIATION OF AMERICA 40bc35c7-a7ea-4181-b897-b62404dfdeec Q1 SPINA BIFIDA ASSOCIATION OF AMERICA 46665 SPINA BIFIDA ASSOCIATION OF AMERICA 2024 first_quarter MED Appropriations Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   75647 0 0 2024-04-18T11:44:04-04:00
3150994 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f0f2cca4-77ae-450d-b217-92c3cd305222 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2024 first_quarter MED HR4365/S2587, FY24 Defense Appropriations Act, Defense Health Research Programs HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-04-18T12:22:11-04:00
3151016 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7fcb2c65-2448-47a5-b008-85047f997cb3 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2024 first_quarter MED HR 4365/S 2587, FY24 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program; HR 5894/S 2624, FY24 Labor HHS Education Act, NIH research on pancreatic cancer HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-04-18T12:25:51-04:00
3151039 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2acec799-6dc1-464b-867e-17197bf1a085 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2024 first_quarter MED HR 4365/S 25, FY24 Defense Appropriations Act, DoD funding for peripheral neuropathy research; HR 5894/S 2624, FY24 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-04-18T12:27:30-04:00
3151048 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 98832917-56d5-4291-906e-efd06afa8eff Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2024 first_quarter MED HR 4365/S 2587, FY24 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; HR5894/S 2624, FY24 Labor HHS Education Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance. HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-04-18T12:30:04-04:00
3151054 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 89dca159-6c72-4d90-9fc7-303b7994087e Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 KIDNEYCAN 2024 first_quarter MED HR 5894/S 2624, FY24 Labor-HHS-Education Appropriations Act, kidney cancer research at NIH HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-04-18T12:31:16-04:00
3151057 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ddcbdddf-31e6-4590-8cbc-f8a93855179f Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 VHL ALLIANCE 2024 first_quarter MED HR 4365/S 2587, FY24 Defense Appropriations Act, DoD research on Von Hippel-Lindau syndrome; HR 5894/S 2624, FY24 Labor HHS Education Act, NIH research on Von Hippel-Lindau syndrome. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-04-18T12:32:29-04:00
3151078 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 79d456fc-1172-4f17-b598-2b0afdc7cb6d Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL CMV FOUNDATION 2024 first_quarter MED HR 4365/S 2587, FY24 Defense Appropriations Act, DoD research on congential CMV; HR 5894/S 2624, FY24 Labor HHS Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance; HR7542/S3757, Stop CMV Act HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-04-18T12:36:46-04:00
3151086 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 164823e3-cc82-4561-8dc3-3abc72840a15 1A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2024 first_quarter MED HR4365/S2587, FY24 Defense Appropriations Act, Defense Health Research Programs HR2882 Further Consolidated Appropriations Act of FY2024 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-04-18T12:37:57-04:00
3151177 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 9d1ba7f9-7384-4e8f-a23d-f84f338fd4ab Q1 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2024 first_quarter MED none     189000 0 0 2024-04-18T12:57:15-04:00
3151183 BUCHANAN INGERSOLL & ROONEY PC 5a27fe3a-137b-4228-8975-d1eabd9e64e4 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 VIVANT BEHAVIORAL HEALTHCARE 2024 first_quarter MED Monitor, evaluate and respond on issues related to residential treatment centers HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-04-18T12:57:35-04:00
3151198 BUCHANAN INGERSOLL & ROONEY PC 847513bc-7f6b-4776-baee-726358b40ed6 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 SYNGAP1 FOUNDATION 2024 first_quarter MED Develop and execute a government relations strategy aligning SYNGAP1s agenda with the current environment in Washington, D.C. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-04-18T13:00:26-04:00
3151511 NEW LANTERN, LLC 19f0dc52-0297-43cb-81ac-5dbe12a35c8b Q1 NEW LANTERN, LLC 401105809 STEEL JUPITER, INC. 2024 first_quarter MED Inquiries and discussions related to COVID-19, virus and health protection, and small business. Commerce, Dept of (DOC),Energy, Dept of,Health & Human Services, Dept of (HHS),SENATE,Small Business Administration (SBA),White House Office 20000   0 0 2024-04-18T13:41:30-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 3457.94ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API